Advertisement
News
Subscribe to MDT Magazine News

VIDEO From Siemens and Synaptic Digital: Not Your Father's X-Ray Machine

December 17, 2010 8:32 am | by Bio-Medicine.Org | Comments

NEW YORK, Dec. 17, 2010 /- Say so-long to the days of black and white 2-D X-rays and images. From CT, to MRI and PET, medical imaging is faster, more detailed, and three-dimensional and is revolutionizing the way medicine is practiced.  Thanks to years of improved imaging, today's...

TOPICS:

Cephalon founder, CEO Frank Baldino Jr. dies at 57

December 17, 2010 7:45 am | by The Associated Press | Comments

Cephalon Inc. Chairman and CEO Frank Baldino Jr. died Thursday evening, the biotechnology company said. He was 57.Chief Operating Officer J. Kevin Buchi took over Baldino's day-to-day responsibilities in August and will continue doing that, said Fritz Bittenbender, vice president for public...

An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety

December 17, 2010 7:31 am | by Bio-Medicine.Org | Comments

NEW YORK, Dec. 17, 2010 /- A study published this week by ITG (NYSE: ITG ) revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year.  ...

TOPICS:
Advertisement

BG Medicine backs out of IPO

December 17, 2010 6:31 am | by Mass High Tech: The Journal of New England Technology | Comments

On the cusp of going public, BG Medicine Inc. has pulled its IPO, Dow Jones reports. BG, which is developing a cardiac diagnostic test, initially filed to go public in January with plans for an $86.3 million offering before scaling back twice prior to pulling the plug.

TOPICS:

Cardinal Health Receives Regulatory Clearance for Kinray Acquisition

December 17, 2010 6:31 am | by Bio-Medicine.Org | Comments

DUBLIN, Ohio, Dec. 17, 2010 /- Cardinal Health today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for its proposed acquisition of Kinray, Inc., a leading pharmaceutical...

TOPICS:

Call for speakers to present at IQPC's MEDCon, the Medical Electronic Device Conference and Expo

December 17, 2010 5:36 am | by MEDCon | Comments

The Medical Electronic Device Conference & Expo (MEDCon), being held May 16 - 18, 2011 at Navy Pier in Chicago focuses on specific needs of electrical and design engineers for medical devices.

TOPICS:

Beetroot juice could help people live more active lives

December 17, 2010 5:31 am | by EurekAlert | Comments

(University of Exeter) New research into the health benefits of beetroot juice suggests it's not only athletes who can benefit from its performance enhancing properties -- its physiological effects could help the elderly or people with heart or lung-conditions enjoy more active lives.

TOPICS:

The high price of sleep disorders

December 17, 2010 5:30 am | by EurekAlert | Comments

(University of Copenhagen) Danish sleep researchers at the University of Copenhagen and the Danish Institute for Health Services Research have examined the socio-economic consequences of the sleep disorder hypersomnia in one of the largest studies of its kind. The sleep disorder has...

TOPICS:
Advertisement

Friday Microcap Tips: Colorado Goldfields Inc., Greenshift Corp., Electric Car Co. Inc., Wellstar Int'l Inc., Camelot Entertainment Group Inc., dPollution International Inc.

December 17, 2010 4:45 am | by The Associated Press | Comments

MicroCapsDaily.com, a leading authority for micro cap research, provides in-depth due diligence and analysis of stocks in every corner of the market. MicroCapsDaily Investment Stock Report's primary mission is to anticipate which small cap and micro cap companies are on the verge of...

Functional Technologies Raises $4,000,000

December 17, 2010 4:45 am | by The Associated Press | Comments

http://www.functionaltechcorp.com () —Functional Technologies Corp. (TSX VENTURE: FEB) reports that the non-brokered private placement announced in its news releases of December 3 and 8, 2010 has closed raising gross proceeds of approximately $4,000,000 by the issuance of 7,272,845 units....

Drug Combinations That May Cause Major Drug Interactions Common Among Seniors Who Take Antidepressants, According to Thomson Reuters Research

December 17, 2010 2:31 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., Dec. 17, 2010 /- More than half of older Americans who were prescribed antidepressants for the first time were already taking a medication that could adversely interact with the antidepressant , according to a new study from Thomson Reuters. For one-fourth of the seniors...

TOPICS:

Drug used in Okla. execution could gain wider use

December 16, 2010 10:45 pm | by SEAN MURPHY - Associated Press - Associated Press | Comments

A sedative Oklahoma used to execute a death row inmate that is commonly used to euthanize animals could become more popular because of a nationwide shortage of a key ingredient in several states' lethal injection formulas, death penalty experts say.John David Duty is believed to be the first...

Non-Profit Breastcancer.org Shares Concerns with FDA on Avastin Breast Cancer Recommendation

December 16, 2010 8:32 pm | by Bio-Medicine.Org | Comments

ARDMORE, Pa., Dec. 16, 2010 /PRNewswire-USNewswire/ -- Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to...

TOPICS:

U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels

December 16, 2010 4:36 pm | by Bio-Medicine.Org | Comments

WAYNE, N.J., Dec. 16, 2010 /- Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate...

TOPICS:

Zimmer Holdings to Present at 29th Annual J.P. Morgan Healthcare Conference

December 16, 2010 4:35 pm | by Bio-Medicine.Org | Comments

WARSAW, Ind., Dec. 16, 2010 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, announced that it will be participating in the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on January 10, 2011, at 12 p.m. Eastern Time. A...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading